The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
Authors
Su-Ni Tang
Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
Chandan Singh
Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
Dara Nall
Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
Daniel Meeker
Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
Sharmila Shankar
Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
Rakesh K Srivastava
Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
DOI: https://doi.org/10.1186/1750-2187-5-14 | Journal eISSN: 1750-2187
Language: English
Published on: Aug 18, 2010
Published by: Danny N. Dhanasekaran
In partnership with: Paradigm Publishing Services
© 2010 Su-Ni Tang, Chandan Singh, Dara Nall, Daniel Meeker, Sharmila Shankar, Rakesh K Srivastava, published by Danny N. Dhanasekaran
This work is licensed under the Creative Commons Attribution 4.0 License.